Estimation of treatment policies based on functional predictors

Statistica Sinica

Volumn 24, Issue 3, 2014, Pages 1461-1485

  McKeague, Ian W ^a   Qian, Min ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Empirical processes; Functional data analysis; Inverse treatment probability weighting; Locally efficient estimation

Indexed keywords

EID: 84919875390     PISSN: 10170405     EISSN: None     Source Type: Journal    
DOI: 10.5705/ss.2012.196     Document Type: Article

References (46)

1. Byar D. P. and Corle, D. K. (1977). Selecting optimal treatment in clinical trials using covariate information. J. Chronic Diseases 30, 445-459.
2. Cai, T., Tian, L., Lloyd-Jones, D. and Wei, L.J. (2013). Evaluating subject-level incremental values of new markers for risk classification rule. Lifetime Data Anal. 19, 547-567
3. Cai, T., Tian, L., Uno, H., Solomon, S. D. andWei, L. J. (2010). Calibrating parametric subjectspecific risk estimation. Biometrika 92, 389-404.
4. Cancer Genome Atlas Research Network (2008). Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068.
5. Cardot, H., Ferraty, F. and Sarda, P. (2003). Spline estimators for the functional linear model. Statist. Sinica 13, 571-591.
6. Cohen, J. (1988). Statistical Power Analysis for the Behavioral Sciences. 2nd edition. Lawrence Erlbaum Associates, Hillsdale, NJ.
7. Dettling, M. and Bühlmann, P. (2004). Finding predictive gene groups from microarray data. J. Multivariate Anal. 90, 106-131.
8. DeRubeis, R. J., Siegle, G. J. and Hollon, S. D. (2008). Cognitive therapy vs. medications for depression: treatment outcomes and neural mechanisms. Nature Reviews Neuroscience 9, 788-796.
9. Engler, D. and Li, Y. (2009). Survival analysis with high-dimensional covariates: an application in microarray studies. Statist. Appl. Genet. Mol. Biol. 1, Article 14.
10. Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC Study). http://embarc.utsouthwestern.edu
11. Fan, J. and Lv, J. (2008). Sure independence screening for ultra-high dimensional feature space (with discussion). J. Roy. Statist. Soc. Ser. B 70, 849-911.
12. Gail, M. and Simon, R. (1985). Testing for qualitative interactions between treatment effects and patient subsets. Biometrics 41, 361-372.
13. Gui, J. and Li, H. (2005). Penalized Cox regression analysis in the high-dimensional and low sample size settings, with applications to microarray gene expression data. Bioinformatics 21, 3001-3008.
14. Heidecker, B. and Hare, J. M. (2007). The use of transcriptomic biomarkers for personalized medicine. Heart Failure Rev. 12, 1-11.
15. James, G. M. and Silverman, B. W. (2005). Functional adaptive model estimation. J. Amer. Statist. Assoc. 100, 565-576.
16. Koomen, J. M., Haura, E. B., Bepler, G., Sutphen, R., Remily-Wood, E. R., Benson, K., Hussein, M., Hazlehurst, L. A., Yeatman, T. J., Hildreth, L. T., Sellers, T. A., Jacobsen, P. B., Fenstermacher, D. A. and Dalton, W. S. (2008). Proteomic contributions to personalized cancer care. Molecular & Cellular Proteomics 7, 1780-1794.
17. Kosorok, M. R. (2008). Introduction to Empirical Processes and Semiparametric Inference. Springer, New York.
18. Kuelbs, J., Kurtz, T. and Zinn, J. (2013). A CLT for empirical processes involving timedependent data. Ann. Probab. 41, 785-816.
19. Laber, E. and Murphy, S. A. (2011). Adaptive confidence intervals for the test error in classification. J. Amer. Statist. Assoc. 106, 904-913.
20. Laber, E., Lizotte, D., Qian, M. and Murphy, S. A. (2010). Statistical inference in dynamic treatment regimes. Preprint, arXiv:1006.5831v2 [stat.ME].
21. Lu, W, Zhang, H. H. and Zeng, D. (2013). Variable selection for optimal treatment decision. Statist. Meth. Medical Res. 22, 493-504.
22. Lunceford, J. K., Davidian, M. and Tsiatis, A. A. (2002). Estimation of survival distributions of treatment policies in two-stage randomization designs in clinical trials. Biometrics 58, 48-57.
23. Murphy, S. A., van der Laan, M. J., Robins, J. M. and CPPRG (2001). Marginal mean models for dynamic regimes. J. Amer. Statist. Assoc. 96, 1410-1423.
24. Murphy, S. A. (2003). Optimal dynamic treatment regimes (with discussion). J. Roy. Statist. Soc. Ser. B 65, 331-366.
25. Murphy, S. A. (2005). A generalization error for Q-learning. J. Mach. Learn. Res. 6, 1073-1097.
26. Qian, M. and Murphy, S. A. (2011). Performance guarantees for individualized treatment rules. Ann. Statist. 39, 1180-1210.
27. Revuz, D. and Yor, M. (2006). Continuous Martingales and Brownian Motion. Springer, New York.
28. Robins, J. M. (1986). A new approach to causal inference in mortality studies with sustained exposure periods - application to control of the healthy worker survivor effect. Mathematical Modelling 7, 1393-1512.
29. Robins, J. M. (2000). Marginal structural models versus structural nested models as tools for causal inference. In Statistical Models in Epidemiology, the Environment, and Clinical Trials (Edited by M. E. Halloran and D. Berry), 95-134. Springer, New York.
30. Robins, J. M. (2004). Optimal regime structural nested models. In Proceedings of the Second Seattle Symposium on Biostatistics, Lecture Notes in Statistics (Edited by D.Y. Lin and P. J. Heagerty). Springer, New York.
31. Shuster, J. and Van Eys, J. (1983). Interaction between prognostic factors and treatment. Controlled Clinical Trials 4, 209-214.
32. Song, X. and Pepe, M. S. (2004). Evaluating markers for selecting a patient's treatment. Biometrics 60, 874-883.
33. Song, X. and Zhou, X.-H. (2011). Evaluating markers for treatment selection based on survival time. Statist. Medicine 30, 2251-2264.
34. Taguchi, A., Politi, K., Pitteri, S. J., Lockwood, W. W., Faca, V. M., Kelly-Spratt, K, Wong, C.-H., Zhang, Q., Chin, A., Park, K.-S., Goodman, G., Gazdar, A. F., Sage, J., Dinulescu, D. M., Kucherlapati, R., DePinho, R. A., Kemp, C. J., Varmus, H. E. and Hanash, S. M. (2011). Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell 20, 289-299.
35. Thall, P. F., Millikan, R. E. and Sung, H. G. (2000). Evaluating multiple treatment courses in clinical trials. Statist. Medicine 19, 1011-1028.
36. Thall, P. F., Sung, H. G. and Estey, E. H. (2002). Selecting therapeutic strategies based on efficacy and death in multicourse clinical trials. J. Amer. Statist. Assoc. 97, 29-39.
37. Tibshirani, R. (1996). Regression shrinkage and selection via the lasso. J. Roy. Statist. Soc. Ser. B 32, 135-166.
38. Tibshirani, R., Saunders, M., Rosset, S., Zhu, J. and Knight, K. (2005). Sparsity and smoothness via the fused lasso. J. Roy. Statist. Soc. Ser. B 67, 91-108.
39. Tsiatis, A. (2006). Semiparametric Theory and Missing Data. Springer, New York.
40. Wahed, A. S. and Tsiatis, A. A. (2006). Semiparametric efficient estimation of survival distribution for treatment policies in two-stage randomization designs in clinical trials with censored data. Biometrika 93, 163-177.
41. van der Laan, M. J., Petersen, M. L. and Joffe, M.M. (2005). History-adjusted marginal structural models and statically-optimal dynamic treatment regimens. Internat. J. Biostatist. 1, Article 4.
42. van der Vaart, A. W. and Wellner, J. A. (1996). Weak Convergence and Empirical Processes. Springer, New York.
43. van der Vaart, A. W. (1998). Asymptotic Statistics. Cambridge University Press.
44. van 't Veer, L. J. and Bernards, R. (2008). Enabling personalized cancer medicine through analysis of gene expression patterns. Nature 452, 564-570.
45. Zhang, B., Tsiatis, A. A., Laber, E. B. and Davidian, M. (2012). A robust method for estimating optimal treatment regimes. Biometrics 68, 1010-1018.
46. Zhao, Y., Zeng, D., Rush, A. J. and Kosorok, M. R. (2012). Estimating individualized treatment rules using outcome weighted learning. J. Amer. Statist. Assoc. 107, 1106-1118.